FDA Inspection 1281017 — James A. Tumlin, MD
The FDA completed an inspection of James A. Tumlin, MD on September 4, 2025 in Lawrenceville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 4, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lawrenceville, GA (United States)
Additional Details
Clinical Investigator (CI)